THE DEAL, AT A GLANCE
From the announcementSeer Bio
01Who is involvedBacked by Baillie Gifford, VariousFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02What happenedSeer Bio raised $80M Series EFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03Why it mattersSeer Bio is financing an AI proteomics platform aimed at proteomics-based biomarker discovery in oncology, anchored by a blood-based Proteograph platform that analyzes…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Seer Bio · Financing Record
Explore source-linked visual explanations for Seer Bio. Unsupported claims are withheld while source review continues.
Record 462 · Recorded date: Needs review
What it does
Unsupported business claims are withheld pending source review. Explore the linked records for available evidence.
Explore company records →